128 related articles for article (PubMed ID: 34913590)
61. FDG-PET/CT in pediatric solid tumors.
Franzius C
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):401-10. PubMed ID: 20823808
[TBL] [Abstract][Full Text] [Related]
62. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
Kessinger CW; Qi G; Hassan MZO; Henke PK; Tawakol A; Jaffer FA
Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011898. PubMed ID: 33724049
[TBL] [Abstract][Full Text] [Related]
63. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
64. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
65. High (18)F-FDG uptake in urinary calculi on PET/CT: An unrecognized non-malignant accumulation.
Fu Z; Li Z; Huang J; Zhang J; Liu M; Li Q; Li Y
Eur J Radiol; 2016 Aug; 85(8):1395-9. PubMed ID: 27423678
[TBL] [Abstract][Full Text] [Related]
66.
Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
[No Abstract] [Full Text] [Related]
67. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
68. Imaging in Post-COVID Lung Disease: Does
Gheysens O; Belkhir L; Jamar F
J Nucl Med; 2022 Feb; 63(2):268-269. PubMed ID: 34675111
[No Abstract] [Full Text] [Related]
69. Benefits of
Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H
Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795
[TBL] [Abstract][Full Text] [Related]
70. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
Shmidt E; Nehra V; Lowe V; Oxentenko AS
BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
[TBL] [Abstract][Full Text] [Related]
71. Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
Öztürk H
Cancer Res Treat; 2015 Oct; 47(4):834-43. PubMed ID: 25687863
[TBL] [Abstract][Full Text] [Related]
72. Diagnostic Value of
Venet M; Jalal Z; Ly R; Malekzadeh-Milani S; Hascoët S; Fournier E; Ovaert C; Casalta AC; Karsenty C; Baruteau AE; Le Gloan L; Selegny M; Douchin S; Bouvaist H; Belaroussi Y; Camou F; Tlili G; Thambo JB
JACC Cardiovasc Imaging; 2022 Feb; 15(2):299-308. PubMed ID: 34538632
[TBL] [Abstract][Full Text] [Related]
73. Whole-Body [
Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
[TBL] [Abstract][Full Text] [Related]
74. Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
Park S; Lee HY; Lee S
J Cancer Res Clin Oncol; 2022 Jan; 148(1):215-224. PubMed ID: 34106327
[TBL] [Abstract][Full Text] [Related]
75. The role of
Rubello D; Marzola MC; Colletti PM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):50-51. PubMed ID: 30391285
[No Abstract] [Full Text] [Related]
76. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
[TBL] [Abstract][Full Text] [Related]
77. Imaging in endocrinology: Langherans cell histiocytosis of the thyroid gland detected by 18FDG-PET/CT.
Giovanella L; Ceriani L; Crippa S; Mazzucchelli L
J Clin Endocrinol Metab; 2007 Aug; 92(8):2866-7. PubMed ID: 17682085
[No Abstract] [Full Text] [Related]
78. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
79.
Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
[TBL] [Abstract][Full Text] [Related]
80. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
